Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 24675489)

1.

Breast cancer bone metastases: an epidemiologic study in selected radiation departments.

Runco R, Laganà S, Marino G, Di Grazia A, Marino L, Umina V, Girlando A, Ricottone N, D'Agostino A, Marletta F, Tamburo M, Corsaro G, Rallo F, Santacaterina A, Acquaviva G, Crispi M, Palazzolo C, Platania A, Spatola C, Privitera G, Frosina P, Garufi G, Bonanno S, Rosso A, Barone V, Corallo A, Sansotta G, Delia P, Donato V, Lopes S, Pisana M, Borzì F, Iatì G, Potami A, Messina G, Parisi S, Frosina L, Marletta D, De Renzis C, Pontoriero A, Pergolizzi S.

Tumori. 2014 Jan-Feb;100(1):38-41. doi: 10.1700/1430.15813.

2.

Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.

Jensen AØ, Jacobsen JB, Nørgaard M, Yong M, Fryzek JP, Sørensen HT.

BMC Cancer. 2011 Jan 24;11:29. doi: 10.1186/1471-2407-11-29.

3.

External beam irradiation in the palliation of bone metastases: a practice analysis among Sicilian Departments of Radiation Oncology.

Pergolizzi S, Pontoriero A, Delia P, Santacaterina A.

Tumori. 2004 Jan-Feb;90(1):86-90.

PMID:
15143978
4.

Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer.

Hess G, Barlev A, Chung K, Hill JW, Fonseca E.

Radiat Oncol. 2012 Oct 12;7:168. doi: 10.1186/1748-717X-7-168.

5.

Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.

Oster G, Lamerato L, Glass AG, Richert-Boe KE, Lopez A, Chung K, Richhariya A, Dodge T, Wolff GG, Balakumaran A, Edelsberg J.

Support Care Cancer. 2013 Dec;21(12):3279-86. doi: 10.1007/s00520-013-1887-3. Epub 2013 Jul 25.

PMID:
23884473
6.

Papillary thyroid cancer incidence in the volcanic area of Sicily.

Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Frasca F, Malandrino P, Vermiglio F, Previtera DM, D'Azzò G, Trimarchi F, Vigneri R.

J Natl Cancer Inst. 2009 Nov 18;101(22):1575-83. doi: 10.1093/jnci/djp354. Epub 2009 Nov 5.

7.

Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis.

Oka H, Kondoh T, Seichi A, Hozumi T, Nakamura K.

J Orthop Sci. 2006 Jan;11(1):13-9.

PMID:
16437343
8.
9.

Prevalence and incidence of multiple sclerosis in Catania, Sicily.

Nicoletti A, Lo Bartolo ML, Lo Fermo S, Cocuzza V, Panetta MR, Marletta C, Ciancio MR, Cataldi ML, Patti F, Reggio A.

Neurology. 2001 Jan 9;56(1):62-6.

PMID:
11148237
10.

Incidence of bone metastases in breast cancer patients in the United Kingdom: results of a multi-database linkage study using the general practice research database.

Hagberg KW, Taylor A, Hernandez RK, Jick S.

Cancer Epidemiol. 2013 Jun;37(3):240-6. doi: 10.1016/j.canep.2013.01.006. Epub 2013 Feb 13.

PMID:
23416031
11.

Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence.

Niibe Y, Kuranami M, Matsunaga K, Takaya M, Kakita S, Hara T, Sekiguchi K, Watanabe M, Hayakawa K.

Anticancer Res. 2008 Nov-Dec;28(6B):3929-31.

12.

Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients.

Wedin R, Bauer HC, Rutqvist LE.

Cancer. 2001 Jul 15;92(2):257-62.

PMID:
11466677
13.
14.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
15.

Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.

Ding X, Fan Y, Ma F, Li Q, Wang J, Zhang P, Yuan P, Xu B.

Breast. 2012 Aug;21(4):544-9. doi: 10.1016/j.breast.2012.04.008. Epub 2012 May 22.

PMID:
22627092
16.

[Breast neoplasms in the Province of Catania: data from the Integrated Neoplasms Registry, Catania-Messina-Siracusa, 2003-2005].

Sciacca S, Sciacchitano S, Fidelbo M, Benedetto G, Madeddu A, Vasquez E, Cordio S, Caltavituro G, Castaing M, Cutello P, Pesce P, Ragusa R, Sciacchitano C, Torrisi A, Torrisi A.

Epidemiol Prev. 2009 Jan-Apr;33(1-2 Suppl 1):59-69. Italian. No abstract available.

PMID:
19623701
17.

Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting.

Trinkaus M, Simmons C, Myers J, Dranatisaris G, Clemons M.

Support Care Cancer. 2010 Feb;18(2):197-203. doi: 10.1007/s00520-009-0645-z. Epub 2009 May 8.

PMID:
19424729
18.

Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.

Berman AT, Thukral AD, Hwang WT, Solin LJ, Vapiwala N.

Clin Breast Cancer. 2013 Apr;13(2):88-94. doi: 10.1016/j.clbc.2012.11.001. Epub 2012 Dec 5.

PMID:
23218473
19.

Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions.

Quattrocchi CC, Piciucchi S, Sammarra M, Santini D, Vincenzi B, Tonini G, Grasso RF, Zobel BB.

Radiol Med. 2007 Oct;112(7):1049-59. Epub 2007 Oct 21. English, Italian.

PMID:
17952675
20.

The implication of hot spots on bone scans within the irradiated field of breast cancer patients treated with mastectomy followed by radiotherapy.

Park W, Huh SJ, Yang JH, Nam SJ, Kim JH, Choi JY, Woo SY, Kim HY, Noh JM, Ryu JI.

Ann Nucl Med. 2008 Oct;22(8):685-91. doi: 10.1007/s12149-008-0158-8. Epub 2008 Nov 4.

PMID:
18982471
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk